KRUUSE Sacryl Plus Suture is a synthetic, absorbable, sterile, surgical suture composed of 90% glycolide and 10% L-lactide (Polyglactin 910) and is coated with glycolide, lactide (Polyglactin 370), and calcium stearate. KRUUSE Sacryl Plus Suture is coated with copolymer of glycolide and lactide (Polyglactin 370) and calcium stearate.
The suture contains chlorhexidine diacetate, a broad-spectrum antibacterial agent. The copolymers in this product have been found to be non-antigenic, non-pyrogenic and elicit only a mild tissue reaction during absorption.
The suture is available in violet.
Complete mass absorption in 56-70 days (approximately 75% of original tensile strength 14 days after implantation, 40% of original tensile strength 21 days after implantation, 20% of original tensile strength 28 days after implantation).

Indications
KRUUSE Sacryl Sutures are indicated for soft tissue approximation and ligation, where absorbable sutures are indicated, including:
■ Blood vessel ligation
■ Ductus ligation
■ Gynaecology and abstretics
■ Ligament ligation
■ Linia alba
■ Muscle repairment and approximation
■ Periocular surgery
■ Subcutaneus approximation

Contraindications
Where permanent support is required
KRUUSE Sacryl Plus Suture should not be used in patients with known allergic reactions to chlorhexidine diacetate

Range
USP 4-0 to 0
EP 1.5 to 3.5

Sterilisation method: EO